about
Oral insulin delivery: how far are we?Epigallocatechin Gallate Nanodelivery Systems for Cancer TherapyCo-encapsulation of lyoprotectants improves the stability of protein-loaded PLGA nanoparticles upon lyophilization.Effect of the Freezing Step in the Stability and Bioactivity of Protein-Loaded PLGA Nanoparticles Upon Lyophilization.A fast and reliable spectroscopic method for the determination of membrane--water partition coefficients of organic compounds.Shedding light on the puzzle of drug-membrane interactions: Experimental techniques and molecular dynamics simulations.Chiral Derivatives of Xanthones: Investigation of the Effect of Enantioselectivity on Inhibition of Cyclooxygenases (COX-1 and COX-2) and Binding Interaction with Human Serum Albumin.Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application.Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies.First record of Aedes albopictus (Skuse 1894) on São tomé island.Nanoscale Delivery of Resveratrol towards Enhancement of Supplements and NutraceuticalsBrain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E.Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.Flow injection based methods for fast screening of antioxidant capacity.Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation.Automatic flow injection based methodologies for determination of scavenging capacity against biologically relevant reactive species of oxygen and nitrogen.Drug-membrane interactions: significance for medicinal chemistry.Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions.Interaction of nonsteroidal anti-inflammatory drugs with membranes: in vitro assessment and relevance for their biological actions.Quality by design: discussing and assessing the solid dispersions risk.Eradication of Helicobacter pylori: Past, present and future.Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity.Non-Biologic Nanodelivery Therapies for Rheumatoid Arthritis.Apo E-Functionalization of Solid Lipid Nanoparticles Enhances Brain Drug Delivery: Uptake Mechanism and Transport Pathways.Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery.Treatment of Francisella infections via PLGA- and lipid-based nanoparticle delivery of antibiotics in a zebrafish model.Permeation of topically applied caffeine from a food by-product in cosmetic formulations: Is nanoscale in vitro approach an option?The formulation of nanomedicines for treating tuberculosis.Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E.Oxaprozin-Loaded Lipid Nanoparticles towards Overcoming NSAIDs Side-Effects.Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy.Solid Lipid Nanoparticles: A Potential Multifunctional Approach towards Rheumatoid Arthritis Theranostics.Biophysics in cancer: The relevance of drug-membrane interaction studies.Cellular interactions of a lipid-based nanocarrier model with human keratinocytes: Unravelling transport mechanisms.Pyranoxanthones: Synthesis, growth inhibitory activity on human tumor cell lines and determination of their lipophilicity in two membrane models.Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin.
P50
Q24632900-6547F0B6-0D9B-481A-98E9-9A2C79EBA554Q26746909-85A0BE14-424F-4D59-A70D-B4D9354904C5Q30380354-B7FAA8DF-5162-47D3-83EF-B2646FF61D24Q30390835-A6E04A3F-5DBD-447D-82B9-7E4A39D5AF08Q32051358-EFC21D23-A00E-403A-90C9-3D5EA9698086Q33364419-2621FFAA-C824-4852-B58C-6F55384CA8C7Q33851532-A8908C32-F841-4346-8F68-BE59D465A307Q34415605-BFD11DAA-2739-499F-8E97-658BB61426F4Q35122206-08F98395-2BE5-44B4-9F1E-CC6F8530D0FAQ36335077-0DD7AED5-ACBC-4B38-8F8C-54E2429B6265Q36732033-71C2010D-7B18-4F39-ADB9-B92ADFC8BED7Q36783549-CBCBDB54-466F-47E3-B850-AE4E2C51CC57Q37003811-BB9DE897-0887-4C93-8A6F-938A04EB8E2DQ37158892-D615219A-F91E-4126-8EC9-EA626A908E00Q37374440-CCD474D4-CD21-4F26-8736-EB1FA4830267Q37395602-44EEA82D-0936-457D-A483-49201D7BE0F2Q37441834-E51FE1CF-3142-4E3B-A940-C6FB1BB2E23DQ37719567-931A4606-706D-4F16-936E-17C0AA6B0349Q37976865-6496E563-A80E-49B7-8186-0B5616464AA0Q38131890-1A776362-0F49-468F-9233-C150F5834985Q38187202-260CE83E-F261-4854-84FA-CAA9FE295C40Q38223572-69799735-D598-48D2-9980-BBC7AAE55BE9Q38366445-FE8BC6B9-9602-4769-96F7-4D0FF2E3697DQ38558587-820544B3-A2E7-4AA4-B098-6A649F96AA50Q38601656-8C206AAB-12EC-4B92-A175-985D9585EA82Q38616625-4CC69DE7-E4DE-47E9-B6F3-252736B6C640Q38709778-7AB70DC7-F427-4791-A2F5-265A1970EFE5Q38709888-12A3C430-5719-4C3F-B994-DFABBFF2F680Q38719632-07670B63-FE63-4FCC-B4F0-FA2BC3DEC48BQ38738457-C456CF22-4422-4421-BA3B-6E975D19202AQ38816020-5EB8FC43-91F6-475F-A671-A1E70A7AE314Q38819117-1F510F2D-C62D-4C15-ADBD-77A1547A46E2Q38836879-637EA4C0-18CA-4C9D-9990-D1B0680C4A74Q38853628-00CC40D4-648D-4ECA-8D86-C56E044AF802Q38862535-8EA0777B-2696-4AC6-B856-89061650BF0FQ38883566-44135058-11E0-40C0-98E1-6FAA8A5639EDQ39001310-0174E336-7604-4294-9710-1BAD5B6BA50FQ39082716-B042BA5C-CB74-404D-96CB-9B5FC2B5DE38Q39102128-FF86D026-0FDB-4238-98D9-8FB6DC0755CFQ39150259-3FD771E0-7FFC-48F1-9222-4899A7284169
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Salette Reis
@ast
Salette Reis
@en
Salette Reis
@es
Salette Reis
@nl
Salette Reis
@sl
type
label
Salette Reis
@ast
Salette Reis
@en
Salette Reis
@es
Salette Reis
@nl
Salette Reis
@sl
prefLabel
Salette Reis
@ast
Salette Reis
@en
Salette Reis
@es
Salette Reis
@nl
Salette Reis
@sl
P1053
A-9613-2013
P106
P1153
56465484800
7102060107
P21
P31
P3829
P496
0000-0002-0736-2835